Literature DB >> 26249558

Pancreaticoduodenectomy in Florida: do 20-year trends document the salutary benefits of centralization of care?

Carrie E Ryan1, Thomas W Wood1, Sharona B Ross1, Amanda E Smart1, Prashant B Sukharamwala1, Alexander S Rosemurgy1.   

Abstract

BACKGROUND: Concentration of care has been promoted as fostering superior outcomes. This study was undertaken to determine if the concentration of care is occurring in Florida for a pancreaticoduodenectomy, and if so, is it having a salutary effect.
METHODS: The data for a pancreaticoduodenectomy were obtained from the Florida Agency for Health Care Administration for three 3-year periods:1992-1994, 2001-2003, 2010-2012; data were sorted by surgeon volume of pancreaticoduodenectomy during these periods and correlated with post-operative length of stay (LOS), in-hospital mortality and hospital charges (adjusted to 2012 dollars).
RESULTS: Relative to 1992-1994, in 2010-2012 46% fewer surgeons performed 115% more pancreaticoduodenectomies with significant reductions in LOS and in-hospital mortality, and higher charges (P < 0.001 for each). From 1992-1994 to 2010-2012 there was an 18-fold increase in the number of pancreaticoduodenectomies by surgeons completing ≥ 12 per year (n = 45 to n = 806, respectively). During 2010-2012, the more frequently surgeons performed a pancreaticoduodenectomy, the shorter LOS, the lower in-hospital mortality, the greater the likelihood of discharge home and the lower the hospital charges (P < 0.03 for each).
CONCLUSIONS: Over the last 20 years, the concentration of care has occurred in Florida with substantially fewer surgeons undertaking many more pancreaticoduodenectomies with dramatic improvements in LOS and in-hospital mortality, albeit with increased hospital charges.
© 2015 International Hepato-Pancreato-Biliary Association.

Mesh:

Year:  2015        PMID: 26249558      PMCID: PMC4557659          DOI: 10.1111/hpb.12467

Source DB:  PubMed          Journal:  HPB (Oxford)        ISSN: 1365-182X            Impact factor:   3.647


  19 in total

1.  Improving the safety of health care: the leapfrog initiative.

Authors:  A Milstein; R S Galvin; S F Delbanco; P Salber; C R Buck
Journal:  Eff Clin Pract       Date:  2000 Nov-Dec

2.  Frequency with which surgeons undertake pancreaticoduodenectomy determines length of stay, hospital charges, and in-hospital mortality.

Authors:  A S Rosemurgy; M Bloomston; F M Serafini; B Coon; M M Murr; L C Carey
Journal:  J Gastrointest Surg       Date:  2001 Jan-Feb       Impact factor: 3.452

3.  The Leapfrog volume criteria may fall short in identifying high-quality surgical centers.

Authors:  Caprice K Christian; Michael L Gustafson; Rebecca A Betensky; Jennifer Daley; Michael J Zinner
Journal:  Ann Surg       Date:  2003-10       Impact factor: 12.969

4.  Regional availability of high-volume hospitals for major surgery.

Authors:  Justin B Dimick; Samuel R G Finlayson; John D Birkmeyer
Journal:  Health Aff (Millwood)       Date:  2004       Impact factor: 6.301

5.  Effect of hospital volume and experience on in-hospital mortality for pancreaticoduodenectomy.

Authors:  Vivian Ho; Martin J Heslin
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

6.  Risk adjustment in outcome assessment: the Charlson comorbidity index.

Authors:  W D'Hoore; C Sicotte; C Tilquin
Journal:  Methods Inf Med       Date:  1993-11       Impact factor: 2.176

7.  Effect of hospital volume on in-hospital mortality with pancreaticoduodenectomy.

Authors:  J D Birkmeyer; S R Finlayson; A N Tosteson; S M Sharp; A L Warshaw; E S Fisher
Journal:  Surgery       Date:  1999-03       Impact factor: 3.982

8.  Rates of complications and death after pancreaticoduodenectomy: risk factors and the impact of hospital volume.

Authors:  D J Gouma; R C van Geenen; T M van Gulik; R J de Haan; L T de Wit; O R Busch; H Obertop
Journal:  Ann Surg       Date:  2000-12       Impact factor: 12.969

Review 9.  Utility of PET, CT, and EUS to identify pathologic responders in esophageal cancer.

Authors:  Stephen G Swisher; Mary Maish; Jeremy J Erasmus; Arlene M Correa; Jaffer A Ajani; Robert Bresalier; Ritsuko Komaki; Homer Macapinlac; Reginald F Munden; Joe B Putnam; David Rice; W Roy Smythe; Ara A Vaporciyan; Garrett L Walsh; Tsung T Wu; Jack A Roth
Journal:  Ann Thorac Surg       Date:  2004-10       Impact factor: 4.330

10.  Statewide regionalization of pancreaticoduodenectomy and its effect on in-hospital mortality.

Authors:  T A Gordon; H M Bowman; J M Tielsch; E B Bass; G P Burleyson; J L Cameron
Journal:  Ann Surg       Date:  1998-07       Impact factor: 12.969

View more
  6 in total

1.  Preoperative Nomogram Predicts Non-home Discharge in Patients Undergoing Pancreatoduodenectomy.

Authors:  Katelyn F Flick; C Max Schmidt; Cameron L Colgate; Michele T Yip-Schneider; Chris M Sublette; Thomas K Maatman; Mazhar Soufi; Eugene P Ceppa; Michael G House; Nicholas J Zyromski; Attila Nakeeb
Journal:  J Gastrointest Surg       Date:  2020-06-24       Impact factor: 3.452

2.  Mortality and Survival Among Octogenarians with Localized Pancreatic Head Cancer: a National Cancer Database Analysis.

Authors:  Jonathan J Hue; Katherine Bingmer; Kavin Sugumar; Lee M Ocuin; Luke D Rothermel; Jordan M Winter; John B Ammori; Jeffrey M Hardacre
Journal:  J Gastrointest Surg       Date:  2021-02-25       Impact factor: 3.452

3.  Paraesophageal Hernia Repair in the USA: Trends of Utilization Stratified by Surgical Volume and Consequent Impact on Perioperative Outcomes.

Authors:  Francisco Schlottmann; Paula D Strassle; Marco E Allaix; Marco G Patti
Journal:  J Gastrointest Surg       Date:  2017-06-12       Impact factor: 3.452

4.  Feasibility of pancreatectomy following high-dose proton therapy for unresectable pancreatic cancer.

Authors:  Kathryn E Hitchcock; R Charles Nichols; Christopher G Morris; Debashish Bose; Steven J Hughes; John A Stauffer; Scott A Celinski; Elizabeth A Johnson; Robert A Zaiden; Nancy P Mendenhall; Michael S Rutenberg
Journal:  World J Gastrointest Surg       Date:  2017-04-27

5.  The pancreatic surgery registry (StuDoQ|Pancreas) of the German Society for General and Visceral Surgery (DGAV) - presentation and systematic quality evaluation.

Authors:  Ulrich F Wellner; Carsten Klinger; Kai Lehmann; Heinz Buhr; Edmund Neugebauer; Tobias Keck
Journal:  Trials       Date:  2017-04-05       Impact factor: 2.279

6.  Optimizing neoadjuvant radiotherapy for resectable and borderline resectable pancreatic cancer using protons.

Authors:  Romaine Charles Nichols; Michael Rutenberg
Journal:  World J Gastrointest Surg       Date:  2019-07-27
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.